Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Australia"

161 News Found

New very-high-sensitivity rapid antigen test kits hit Australian market
News | April 11, 2022

New very-high-sensitivity rapid antigen test kits hit Australian market

New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia


Trescal launches its single source calibration solution across Australia and New Zealand
Biotech | April 05, 2022

Trescal launches its single source calibration solution across Australia and New Zealand

Trescal provides precision calibration expertise in every industry, geography and instrument across the world


Moderna’s Covid-19 vaccine approved in Australia for children (6-11 years)
News | February 17, 2022

Moderna’s Covid-19 vaccine approved in Australia for children (6-11 years)

Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia


Australia grants provisional registration for Novavax Covid-19 vaccine
Drug Approval | January 20, 2022

Australia grants provisional registration for Novavax Covid-19 vaccine

Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia


Moderna to set up mRNA vaccine manufacturing facility in Australia
Biotech | December 14, 2021

Moderna to set up mRNA vaccine manufacturing facility in Australia

Up to 100 million mRNA vaccine doses could be produced in Australia each year


Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia
Biotech | December 13, 2021

Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia

It is a novel oral NLRP3 inflammasome inhibitor


Lincoln Pharma gets Australian TGA approval
News | October 08, 2021

Lincoln Pharma gets Australian TGA approval

The company plans to expand its portfolio in regulated markets aggressively


Sun Pharma arm to acquire stake in WRS Bioproducts, Australia
News | March 06, 2021

Sun Pharma arm to acquire stake in WRS Bioproducts, Australia

The consideration to be paid will be AUD 2.0 mn for 12.5% stake.


Johnson Matthey sells Medical Device Components business for US$700 million to Montagu
Equipment | March 21, 2024

Johnson Matthey sells Medical Device Components business for US$700 million to Montagu

The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol